Jury Still Out On Success Of FDA's Warning Letter Close-Out Program
This article was originally published in The Tan Sheet
Executive Summary
FDA is extending its warning letter "close-out" pilot program to learn more about its value, even as some experts grumble that the program may not be all it was cracked up to be.
You may also be interested in...
FDA Enforcement Follow-Through Could Thin Out Violators
FDA's emphasis on follow-through in its revamped enforcement strategy may help weed out bad actors from legitimate industry
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.